13F filer · CIK 1422849 ↗
Capital World Investors
You are looking at Q1 2020. See the latest, Q2 2026 →
Reported value
$344.62B
−23% on the quarter before
Positions
521
58 new · 52 sold out
Top 10
26.7%
of the value
Est. gain
−$71.86B
on stocks held all quarter
Est. return
−18.7%
on those stocks since Q4 2019
Positions as of Mar 31, 2020, from Capital World Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 44% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2019. Striped tiles are options.
Largest buys
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Gilead Sciences Inc~$1.91BAdded · 0.3% → 1.0%+25,555,467 shares
- Johnson And Johnson~$1.80BAdded · 0.2% → 0.8%+13,703,905 shares
- Philip Morris International~$1.28BAdded · 1.4% → 1.9%+17,583,436 shares
- Pfizer Inc~$1.18BAdded · 1.7% → 2.1%+36,092,723 shares
- Aon Plc Cl A~$1.05BNew · 0.0% → 0.3%+6,352,625 shares
- Dollar General Corp~$933.5MAdded · 0.2% → 0.5%+6,181,380 shares
- Xcel Energy~$911.2MNew · 0.0% → 0.3%+15,111,385 shares
- AMD~$892.1MAdded · 0.3% → 0.6%+19,615,477 shares
- Shopify Inc Cl A S/V (Usd)~$830.5MAdded · 0.3% → 0.6%+1,991,970 shares
- Colgate-Palmolive Co~$829.7MNew · 0.0% → 0.2%+12,503,612 shares
Largest sells
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$6.54BCut · 6.4% → 6.4%−41,441,394 shares
- Merck And Co Inc~$1.81BCut · 1.3% → 0.9%−23,575,625 shares
- Charter Communications Inc Cl A~$1.49BCut · 0.6% → 0.3%−3,414,317 shares
- Royal Dutch Shell Plc B ADR~$1.32BCut · 0.6% → 0.1%−40,496,738 shares
- Home Depot Inc~$1.30BCut · 1.9% → 1.8%−6,953,059 shares
- Broadcom~$1.25BCut · 3.1% → 2.6%−5,256,986 shares
- Mastercard~$1.21BCut · 1.4% → 1.1%−5,017,961 shares
- Aon Plc Cl A~$1.09BSold out · 0.2% → 0.0%−5,217,957 shares
- Meta~$1.05BCut · 2.1% → 2.0%−6,266,938 shares
- Asml Holding Nv (Usd)~$1.02BCut · 0.9% → 0.7%−3,908,932 shares
Holdings
As of Mar 31, 2020. Changes are in shares against Dec 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOMMON STOCK · shares −23% · price +0.0% | 6.4% | $21.94B | +$1.4M | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares +0.2% · price −15.2% | 3.5% | $11.98B | −$2.14B | ||||||||
| BroadcomCOMMON STOCK · shares −12% · price −25.0% | 2.6% | $9.09B | −$3.03B | ||||||||
| Jpmorgan Chase And CoCOMMON STOCK · shares +9.9% · price −35.4% | 2.4% | $8.20B | −$4.09B | ||||||||
| AmazonCOMMON STOCK · shares +11% · price +5.5% | 2.3% | $8.04B | +$377.1M | ||||||||
| Pfizer IncCOMMON STOCK · shares +19% · price −16.7% | 2.1% | $7.34B | −$1.23B | ||||||||
| MetaCOMMON STOCK · shares −13% · price −18.7% | 2.0% | $6.74B | −$1.55B | ||||||||
| Philip Morris InternationalCOMMON STOCK · shares +24% · price −14.3% | 1.9% | $6.64B | −$890.2M | ||||||||
| Berkshire Hathaway Inc Cl ACOMMON STOCK · shares −8.5% · price −19.9% | 1.8% | $6.06B | −$1.51B | ||||||||
| Home Depot IncCOMMON STOCK · shares −18% · price −14.5% | 1.8% | $6.05B | −$1.03B | ||||||||
| Cme Group Inc Cl ACOMMON STOCK · shares −2.4% · price −13.9% | 1.8% | $6.04B | −$971.3M | ||||||||
| Lockheed Martin CorpCOMMON STOCK · shares +1.5% · price −13.0% | 1.7% | $5.83B | −$855.0M | ||||||||
| TeslaCOMMON STOCK · shares +0.2% · price +25.3% | 1.6% | $5.61B | +$1.13B | ||||||||
| Thermo Fisher Scientific IncCOMMON STOCK · shares +8.0% · price −12.7% | 1.4% | $4.77B | −$643.1M | ||||||||
| NetflixCOMMON STOCK · shares −14% · price +16.0% | 1.4% | $4.66B | +$644.6M | ||||||||
| Boeing CoCOMMON STOCK · shares +15% · price −54.2% | 1.3% | $4.56B | −$4.69B | ||||||||
| MastercardCOMMON STOCK · shares −24% · price −19.1% | 1.1% | $3.80B | −$896.6M | ||||||||
| Regeneron PharmaceuticalsCOMMON STOCK · shares −14% · price +30.0% | 1.0% | $3.48B | +$804.7M | ||||||||
| Csx CorpCOMMON STOCK · shares +6.8% · price −20.8% | 1.0% | $3.48B | −$855.3M | ||||||||
| Gilead Sciences IncCOMMON STOCK · shares +123% · price +15.1% | 1.0% | $3.46B | +$203.2M | ||||||||
| AlphabetCOMMON STOCK · shares −10% · price −13.0% | 1.00% | $3.44B | −$515.5M | ||||||||
| Comcast Corp Cl ACOMMON STOCK · shares +7.8% · price −23.5% | 0.96% | $3.30B | −$943.5M | ||||||||
| Honeywell TechnologiesCOMMON STOCK · shares +28% · price −24.4% | 0.95% | $3.27B | −$825.3M | ||||||||
| Cigna CorpCOMMON STOCK · shares −10.0% · price −13.4% | 0.93% | $3.21B | −$494.5M | ||||||||
| Altria Group IncCOMMON STOCK · shares +11% · price −22.5% | 0.93% | $3.20B | −$838.8M | ||||||||
| Total · 521 positions | 100% | $344.62B | −$71.86B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2019 to Q1 2020: 458 stocks held throughout, down $71.86B (−18.7%).
- Tesla+$1.13B+25%
- Regeneron Pharmaceuticals+$804.7M+30%
- Netflix+$644.6M+16%
- Digital Realty+$439.3M+16%
- RingCentral+$438.3M+26%
- Simon Property Group Inc (Reit)−$1.85B−63%
- Unitedhealth Group Inc−$2.14B−15%
- Broadcom−$3.03B−25%
- Jpmorgan Chase And Co−$4.09B−35%
- Boeing Co−$4.69B−54%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $846.43B+15% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $732.94B−0% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $735.30B+0% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $732.04B+6% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $687.95B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $617.20B−6% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $658.71B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $645.05B+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $613.27B+1% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $604.23B+7% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $562.26B+11% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $504.81B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $519.91B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $483.79B+3% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $469.11B+5% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $445.41B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $470.72B−19% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $580.76B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $632.21B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $585.85B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $588.43B+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $541.07B+4% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $518.94B+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $456.91B+11% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $413.27B+20% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $344.62B−23% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $447.39B+8% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $415.21B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $426.29B+3% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $412.39B+12% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $369.11B−10% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $411.05B−12% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $467.29B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $444.21B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $461.25B+4% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $441.49B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $425.76B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $418.31B+5% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $397.60B+3% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $384.55B+4% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $370.85B+2% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $361.93B | SEC ↗ |